BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Semelka RC, Chung J, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: Correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-91. [DOI: 10.1002/jmri.1055] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Boutry S, Burtea C, Laurent S, Toubeau G, Vander Elst L, Muller RN. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. Magn Reson Med 2005;53:800-7. [DOI: 10.1002/mrm.20403] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
2 Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications. Hepatology 2008;47:332-42. [DOI: 10.1002/hep.21972] [Cited by in Crossref: 232] [Cited by in F6Publishing: 211] [Article Influence: 15.5] [Reference Citation Analysis]
3 Mitchell DG, Navarro VJ, Herrine SK, Bergin D, Parker L, Frangos A, Mccue P, Rubin R. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging. Abdom Imaging 2008;33:58-64. [DOI: 10.1007/s00261-007-9203-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
4 Martin DR, Semelka RC. Magnetic Resonance Imaging of the Liver: Review of Techniques and Approach to Common Diseases. Seminars in Ultrasound, CT and MRI 2005;26:116-31. [DOI: 10.1053/j.sult.2005.02.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chundru S, Kalb B, Arif-Tiwari H, Sharma P, Costello J, Martin DR. MRI of diffuse liver disease: characteristics of acute and chronic diseases. Diagn Interv Radiol 2014;20:200-8. [PMID: 24808418 DOI: 10.5152/dir.2014.13170] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
6 Watanabe H, Kanematsu M, Goshima S, Kondo H, Kajita K, Kawada H, Noda Y, Moriyama N. Detection of focal hepatic lesions with 3-T MRI: comparison of two-dimensional and three-dimensional T2-weighted sequences. Jpn J Radiol 2012;30:721-8. [DOI: 10.1007/s11604-012-0111-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bilgin M, Balci NC, Erdogan A, Momtahen AJ, Alkaade S, Rau WS. Hepatobiliary and pancreatic MRI and MRCP findings in patients with HIV infection. AJR Am J Roentgenol. 2008;191:228-232. [PMID: 18562750 DOI: 10.2214/ajr.07.3197] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Gourtsoyiannis NC, Grammatikakis J, Papamastorakis G, Koutroumbakis J, Prassopoulos P, Rousomoustakaki M, Papanikolaou N. Imaging of small intestinal Crohn’s disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol 2006;16:1915-25. [DOI: 10.1007/s00330-006-0248-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 97] [Article Influence: 7.0] [Reference Citation Analysis]
9 Shin SK, Kim YS, Choi SJ, Shim YS, Jung DH, Kwon OS, Choi DJ, Kim JH. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article. Medicine (Baltimore) 2017;96:e7278. [PMID: 28723741 DOI: 10.1097/MD.0000000000007278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246:812-822. [PMID: 18223123 DOI: 10.1148/radiol.2463070432] [Cited by in Crossref: 401] [Cited by in F6Publishing: 353] [Article Influence: 28.6] [Reference Citation Analysis]
11 Hughes-Cassidy F, Chavez AD, Schlang A, Hassanein T, Gamst A, Wolfson T, Sirlin C. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging. 2007;26:728-737. [PMID: 17685418 DOI: 10.1002/jmri.21066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
12 Schneider G, Grazioli L, Saini S. Techniques for Liver MR Imaging. In: Schneider G, Grazioli L, Saini S, editors. MRI of the Liver. Milano: Springer Milan; 2006. pp. 1-16. [DOI: 10.1007/88-470-0469-1_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Lindbäck SM, Gabbert C, Johnson BL, Smorodinsky E, Sirlin CB, Garcia N, Pardee PE, Kistler KD, Schwimmer JB. Pediatric Nonalcoholic Fatty Liver Disease: A Comprehensive Review. Advances in Pediatrics 2010;57:85-140. [DOI: 10.1016/j.yapd.2010.08.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
14 Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging. Radiology 2006;239:425-37. [DOI: 10.1148/radiol.2392050505] [Cited by in Crossref: 143] [Cited by in F6Publishing: 135] [Article Influence: 8.9] [Reference Citation Analysis]
15 Keller S, Aigner A, Zenouzi R, Kim AC, Meijer A, Weidemann SA, Krech T, Lohse AW, Adam G, Schramm C, Yamamura J. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis. PLoS One. 2018;13:e0193929. [PMID: 29513767 DOI: 10.1371/journal.pone.0193929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology. 2004;230:637-644. [PMID: 14739306 DOI: 10.1148/radiol.2303020921] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
17 Wang H, Wang XY, Jiang XX, Ye ZX. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T. Acad Radiol 2010;17:239-43. [PMID: 19962912 DOI: 10.1016/j.acra.2009.09.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
18 Martin DR. Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imaging. 2002;13:151-163. [PMID: 12357079 DOI: 10.1097/00002142-200206000-00003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
19 Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol (NY). 2017;42:152-158. [PMID: 27472938 DOI: 10.1007/s00261-016-0847-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
20 Shu J, Zhao JN, Han FG, Tang GC, Luo YD, Luo L, Chen X. Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology. World J Radiol 2013; 5(5): 208-214 [PMID: 23805371 DOI: 10.4329/wjr.v5.i5.208] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Balci NC, Befeler AS, Leiva P, Pilgram TK, Havlioglu N. Imaging of liver disease: comparison between quadruple-phase multidetector computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2008;23:1520-7. [PMID: 18713303 DOI: 10.1111/j.1440-1746.2008.05434.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
22 Martin DR, Seibert D, Yang M, Salman K, Frick MP. Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium-enhanced MRI. J Magn Reson Imaging 2004;20:838-42. [PMID: 15503331 DOI: 10.1002/jmri.20192] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
23 Ozaki K, Takeshita M, Saito K, Kimura H, Gabata T. A case of focal confluent hepatic fibrosis in the patient with hepatitis C virus-related liver cirrhosis: a mimic of cholangiolocellular carcinoma. Abdom Radiol (NY) 2020;45:2249-56. [PMID: 32025800 DOI: 10.1007/s00261-020-02428-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Seminars in Ultrasound, CT and MRI 2002;23:79-100. [DOI: 10.1016/s0887-2171(02)90030-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, Tobias H. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799-806. [PMID: 17885048 DOI: 10.2214/ajr.07.2086] [Cited by in Crossref: 265] [Cited by in F6Publishing: 94] [Article Influence: 17.7] [Reference Citation Analysis]
26 Zissen MH, Wang ZJ, Yee J, Aslam R, Monto A, Yeh BM. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. AJR Am J Roentgenol. 2013;201:1204-1210. [PMID: 24261358 DOI: 10.2214/ajr.12.10039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 16] [Article Influence: 5.9] [Reference Citation Analysis]
27 Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 2010;34:1451-67. [DOI: 10.1038/ijo.2010.185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
28 Martí-bonmatí L. MR contrast agents in hepatic cirrhosis and chronic hepatitis. Seminars in Ultrasound, CT and MRI 2002;23:101-13. [DOI: 10.1016/s0887-2171(02)90031-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J. Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagnostic and Interventional Imaging 2017;98:455-68. [DOI: 10.1016/j.diii.2017.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
30 Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 2006;241:459-68. [PMID: 16966482 DOI: 10.1148/radiol.2412051336] [Cited by in Crossref: 227] [Cited by in F6Publishing: 178] [Article Influence: 14.2] [Reference Citation Analysis]
31 Martin DR, Danrad R, Hussain SM. MR imaging of the liver. Radiol Clin North Am 2005;43:861-86, viii. [PMID: 16098344 DOI: 10.1016/j.rcl.2005.05.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
32 Zhao XQ, Kerwin WS. Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy. Clin Lipidol 2012;7:329-43. [PMID: 23197995 DOI: 10.2217/clp.12.33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Kanematsu M, Danet MI, Leonardou P, Mastropasqua M, Mosetti MA, Braga L, Woosley JT, Semelka RC. Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging 2004;20:242-9. [PMID: 15269949 DOI: 10.1002/jmri.20097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
34 Hallinan JT, Alsaif HS, Wee A, Venkatesh SK. Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness. Abdom Imaging. 2015;40:783-788. [PMID: 25331568 DOI: 10.1007/s00261-014-0275-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
35 Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging. 2008;28:89-95. [PMID: 18581382 DOI: 10.1002/jmri.21227] [Cited by in Crossref: 152] [Cited by in F6Publishing: 143] [Article Influence: 10.9] [Reference Citation Analysis]
36 Bilaj F, Hyslop WB, Rivero H, Firat Z, Vaidean G, Shrestha R, Woosley JT, Semelka RC. MR Imaging Findings in Autoimmune Hepatitis: Correlation with Clinical Staging. Radiology 2005;236:896-902. [DOI: 10.1148/radiol.2363041262] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
37 Martí-Bonmatí L, Delgado F. MR imaging in liver cirrhosis: classical and new approaches. Insights Imaging 2010;1:233-44. [PMID: 22347919 DOI: 10.1007/s13244-010-0034-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
38 Papanikolaou N, Gourtsoyianni S. MRI of the Small Bowel: Enteroclysis. In: Stoker J, editor. MRI of the Gastrointestinal Tract. Berlin: Springer Berlin Heidelberg; 2010. pp. 135-48. [DOI: 10.1007/978-3-540-85532-3_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Yu JS, Shim JH, Chung JJ, Kim JH, Kim KW. Double contrast-enhanced MRI of viral hepatitis-induced cirrhosis: correlation of gross morphological signs with hepatic fibrosis. Br J Radiol. 2010;83:212-217. [PMID: 19505965 DOI: 10.1259/bjr/70974553] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
40 Sharma P, Kitajima HD, Kalb B, Martin DR. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations. Top Magn Reson Imaging 2009;20:71-8. [PMID: 20010061 DOI: 10.1097/RMR.0b013e3181c42454] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
41 Lee Y, Lee JS, Kim CM, Jeong JY, Choi JI, Kim MJ. Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver. Magn Reson Imaging 2008;26:577-82. [PMID: 18093780 DOI: 10.1016/j.mri.2007.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
42 Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413-427. [PMID: 17033514 DOI: 10.1097/01.mpg.0000239995.58388.56] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 10.3] [Reference Citation Analysis]
43 Danet I, Semelka RC, Braga L. MR imaging of diffuse liver disease. Radiologic Clinics of North America 2003;41:67-87. [DOI: 10.1016/s0033-8389(02)00060-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
44 Danrad R, Martin DR. MR imaging of diffuse liver diseases. Magn Reson Imaging Clin N Am. 2005;13:277-293, vi. [PMID: 15935312 DOI: 10.1016/j.mric.2005.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
45 Hanana H, Turcotte P, André C, Gagnon C, Gagné F. Comparative study of the effects of gadolinium chloride and gadolinium – based magnetic resonance imaging contrast agent on freshwater mussel, Dreissena polymorpha. Chemosphere 2017;181:197-207. [DOI: 10.1016/j.chemosphere.2017.04.073] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zhao XQ, Yuan C, Shah PK. Imaging to Assess the Effect of Anti-Inflammatory Therapy in Aortic and Carotid Atherosclerosis. J Am Coll Cardiol 2016;68:1781-4. [PMID: 27737745 DOI: 10.1016/j.jacc.2016.08.011] [Reference Citation Analysis]
47 Marri UK, Das P, Shalimar, Kalaivani M, Srivastava DN, Madhusudhan KS. Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings. Radiology 2021;298:600-8. [PMID: 33399510 DOI: 10.1148/radiol.2021202232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
48 Kim SW, Shin HC, Kim IY. Diffuse pattern of transient hepatic attenuation differences in viral hepatitis: a sign of acute hepatic injury in patients without cirrhosis. J Comput Assist Tomogr 2010;34:699-705. [PMID: 20861772 DOI: 10.1097/RCT.0b013e3181dbe5b2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol. 2011;78:129-134. [PMID: 19926420 DOI: 10.1016/j.ejrad.2009.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
50 Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol. 2009;50:17-35. [PMID: 19022517 DOI: 10.1016/j.jhep.2008.10.016] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 9.1] [Reference Citation Analysis]
51 Balassy C, Feier D, Peck-Radosavljevic M, Wrba F, Witoszynskyj S, Kiefer B, Reiter G, Dai Y, Ba-Ssalamah A. Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study. Radiology. 2014;270:149-158. [PMID: 23925270 DOI: 10.1148/radiol.13122440] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
52 Bahl G, Cruite I, Wolfson T, Gamst AC, Collins JM, Chavez AD, Barakat F, Hassanein T, Sirlin CB. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging 2012;36:1154-61. [PMID: 22851409 DOI: 10.1002/jmri.23759] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
53 Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
54 Mou WY, Guo DM, Liu H, Zhang P, Shao Y, Wang SW, Yimin, Zheng L. Staging liver fibrosis by analysis of non-linear normalization texture in gadolinium-enhanced magnetic resonance imaging. Biomed Phys Eng Express 2015;1:045012. [DOI: 10.1088/2057-1976/1/4/045012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Carlos RC, Kim HM, Hussain HK, Francis IR, Nghiem HV, Fendrick AM. Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis. AJR Am J Roentgenol. 2003;180:893-900. [PMID: 12646426 DOI: 10.2214/ajr.180.4.1800893] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
56 Elias J, Altun E, Zacks S, Armao DM, Woosley JT, Semelka RC. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging. Magn Reson Imaging. 2009;27:976-987. [PMID: 19356874 DOI: 10.1016/j.mri.2009.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
57 Sharma P, Kalb B, Kitajima HD, Salman KN, Burrow B, Ray GL, Martin DR. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging. J Magn Reson Imaging. 2011;33:110-118. [PMID: 21182128 DOI: 10.1002/jmri.22200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
58 Wu Z, Matsui O, Kitao A, Kozaka K, Koda W, Kobayashi S, Ryu Y, Minami T, Sanada J, Gabata T. Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. PLoS One. 2015;10:e0118297. [PMID: 25742285 DOI: 10.1371/journal.pone.0118297] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
59 Martin DR, Lauenstein T, Kalb B, Lurie C, Kitajima H, Sharma P, Salman K, Moreira R, Farris AB 3rd, Spivey J, Martinez E, Hanish S, Adsay V. Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging. J Magn Reson Imaging 2012;36:422-9. [PMID: 22566123 DOI: 10.1002/jmri.23668] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
60 Tonan T, Fujimoto K, Qayyum A. Chronic hepatitis and cirrhosis on MR imaging. Magn Reson Imaging Clin N Am 2010;18:383-402, ix. [PMID: 21094446 DOI: 10.1016/j.mric.2010.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]